Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Net Current Assets

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Current Assets (Including Current Investments) ₹1,322 Cr₹4,446 Cr₹2,461 Cr₹1,780 Cr₹2,526 Cr

What is the latest Net Current Assets ratio of MANKIND PHARMA ?

The latest Net Current Assets ratio of MANKIND PHARMA is ₹1,322 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹1,322 Cr
Mar2024₹4,446 Cr
Mar2023₹2,461 Cr
Mar2022₹1,780 Cr
Mar2021₹2,526 Cr

How is Net Current Assets of MANKIND PHARMA Trending?

Years Net Current Assets % Change
Mar2025 ₹1,322 Cr
-70.26
Mar2024 ₹4,446 Cr
80.62
Mar2023 ₹2,461 Cr
38.25
Mar2022 ₹1,780 Cr
-29.52
Mar2021 ₹2,526 Cr -

Compare Net Current Assets of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹97,612.6 Cr -0.3% -5.3% -0.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,667.0 Cr 1.4% -4.5% 6.5% Stock Analytics
DIVIS LABORATORIES ₹176,805.0 Cr 0.1% -2.5% -0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,554.0 Cr -2.7% 1.2% 39.3% Stock Analytics
CIPLA ₹109,120.0 Cr -2.3% -5.3% -9.8% Stock Analytics
DR REDDYS LABORATORIES ₹105,920.0 Cr -0.5% -4.7% -5.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-0.3%

-5.3%

-0.9%

SENSEX

4.3%

2.6%

-6.4%


You may also like the below Video Courses